2024 annual financial data
Ensysce Biosciences 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -144,005,758.16%.
Operating income was -6,730,000 USD and net income was -7,987,000 USD.
Operating cash flow was -7,502,700,000,000 USD.
Get free Ensysce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,210,000 USD
- Operating income
- -6,730,000 USD
- Net income
- -7,987,000 USD
- Operating cash flow
- -7,502,700,000,000 USD